Our study provided compelling evidences that the natural compound α-hederin exerts anti-tumor effects by directly targeting USP5, disrupting its interaction with STAT3, and inhibiting STAT3 deubiquitination-a previously unreported mechanism. Here, USP5 is linked to neoplasm.